2-(But-3-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

Ethyl 3-fluoro-4-methoxybenzoylformate, 96.0%, 250mg

(2E)-3-(3-bromo-4-methoxyphenyl)acrylic acid, 95.0%, 25g

1-isobutyryl-1,2,3,4-tetrahydroquinolin-7-amine, 95.0%, 250mg

1-(4-Bromo-2-fluorophenyl)-2,2,2-trifluoroethan-1-ol, 98%, 250mg

Ethyl 4-(cyclopropylamino)cyclohexanecarboxylate, 97%, 10g

6-Methoxyquinoline-2-carboxylic acid, 95.0%, 500mg

N,N-dibenzylacetamide, 97%, 250mg

5-Bromo-2-furaldehyde>98.0%(GC)5g

2-(Pyridin-2-ylthio)ethanol, 97%, 1g

trans-(1R,2R)-N,N'-Bismethyl-1,2-cyclohexanediamine, 98.0%, 10g

N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropanesulfonamide, 98%, 250mg

Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)methane, 95.0%, 1g